Correspondence on “Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD” - Authors' Reply

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Journal of Hepatology Pub Date : 2025-02-20 DOI:10.1016/j.jhep.2025.02.019

Benedikt Silvester Hofer, Wilhelmus J. Kwanten, Sven Francque

{"title":"Correspondence on “Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD” - Authors' Reply","authors":"Benedikt Silvester Hofer, Wilhelmus J. Kwanten, Sven Francque","doi":"10.1016/j.jhep.2025.02.019","DOIUrl":null,"url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Acknowledgements</h2>The authors wish to thank Rafael Paternostro and Thomas Reiberger for their insights while preparing this letter.</section></section><section><section><h2>Authors' contributions</h2>BS: Analysis of the data; Writing – original draft; Writing – Review and editing;WK: Writing – Review and editing;SF: Writing – Review and editing; Supervision;</section></section><section><section><h2>Financial support</h2>The authors did not receive any financial support for this letter.</section></section><section><section><h2>Declaration of Competing Interest</h2>BS: Travel grant from Ipsen.WK: Co-inventor of a patent on the use lipopigment imaging for disease filed by MIT/MGH; travel grant from Norgine, Ipsen and Abbvie; speakers fee from PanNASH initiative.SF: Senior clinical research mandate from the Fund for Scientific Research (FWO) Flanders (1802154N); advisor and/or lecturer for Roche, Gilead, Abbvie, Bayer, BMS, MSD, Janssen, Actelion, Astellas, Genfit, Inventiva, Intercept, Genentech, Galmed, Promethera, Coherus and NGM Bio.Please refer to the</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"19 1","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhep.2025.02.019","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Section snippets

Acknowledgements

The authors wish to thank Rafael Paternostro and Thomas Reiberger for their insights while preparing this letter.

Authors' contributions

BS: Analysis of the data; Writing – original draft; Writing – Review and editing;WK: Writing – Review and editing;SF: Writing – Review and editing; Supervision;

Financial support

The authors did not receive any financial support for this letter.

Declaration of Competing Interest

BS: Travel grant from Ipsen.WK: Co-inventor of a patent on the use lipopigment imaging for disease filed by MIT/MGH; travel grant from Norgine, Ipsen and Abbvie; speakers fee from PanNASH initiative.SF: Senior clinical research mandate from the Fund for Scientific Research (FWO) Flanders (1802154N); advisor and/or lecturer for Roche, Gilead, Abbvie, Bayer, BMS, MSD, Janssen, Actelion, Astellas, Genfit, Inventiva, Intercept, Genentech, Galmed, Promethera, Coherus and NGM Bio.Please refer to the

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

求助全文

约1分钟内获得全文去求助

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.